Ardelyx Analyst Ratings
Ardelyx Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/01/2023 | 184.61% | HC Wainwright & Co. | $9 → $11 | Maintains | Buy |
| 09/13/2023 | 81.11% | Wedbush | → $7 | Reiterates | Outperform → Outperform |
| 09/12/2023 | 132.86% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 09/07/2023 | 132.86% | HC Wainwright & Co. | → $9 | Initiates Coverage On | → Buy |
| 08/25/2023 | 158.73% | Cantor Fitzgerald | $5 → $10 | Upgrades | Neutral → Overweight |
| 08/03/2023 | 119.92% | Ladenburg Thalmann | $7.5 → $8.5 | Maintains | Buy |
| 04/17/2023 | 81.11% | Wedbush | $6 → $7 | Maintains | Outperform |
| 03/03/2023 | 55.24% | Wedbush | $3 → $6 | Upgrades | Neutral → Outperform |
| 12/30/2022 | 81.11% | Citigroup | $6 → $7 | Maintains | Buy |
| 11/17/2022 | 106.99% | Piper Sandler | $3 → $8 | Upgrades | Neutral → Overweight |
| 05/19/2022 | -22.38% | Piper Sandler | $4 → $3 | Maintains | Neutral |
| 05/06/2022 | — | Cantor Fitzgerald | Downgrades | Overweight → Neutral | |
| 03/02/2022 | 29.37% | Jefferies | $1 → $5 | Upgrades | Hold → Buy |
| 12/01/2021 | 236.35% | Citigroup | $7 → $13 | Maintains | Buy |
| 12/01/2021 | 55.24% | Ladenburg Thalmann | → $6 | Upgrades | Neutral → Buy |
| 10/14/2021 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral | |
| 07/21/2021 | -48.25% | Jefferies | $11 → $2 | Downgrades | Buy → Hold |
| 07/20/2021 | -22.38% | Wedbush | → $3 | Downgrades | Outperform → Neutral |
| 07/20/2021 | 3.49% | Piper Sandler | $14 → $4 | Downgrades | Overweight → Neutral |
| 03/23/2021 | 262.23% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
| 01/06/2021 | 262.23% | Cantor Fitzgerald | → $14 | Initiates Coverage On | → Overweight |
| 12/11/2020 | 262.23% | SVB Leerink | $11 → $14 | Maintains | Outperform |
| 02/18/2020 | 184.61% | Jefferies | → $11 | Assumes | → Buy |
| 02/12/2020 | 236.35% | Citigroup | → $13 | Initiates Coverage On | → Buy |
| 02/10/2020 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 09/24/2019 | 132.86% | SVB Leerink | $8 → $9 | Maintains | Outperform |
| 04/08/2019 | — | Piper Sandler | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/01/2023 | 184.61% | HC Wainwright & Co. | 9 美元 → 11 美元 | 維護 | 買 |
| 09/13/2023 | 81.11% | Wedbush | → 7 美元 | 重申 | 跑贏大盤 → 跑贏大盤 |
| 09/12/2023 | 132.86% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 09/07/2023 | 132.86% | HC Wainwright & Co. | → 9 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 08/25/2023 | 158.73% | 坎託·菲茨傑拉德 | 5 美元 → 10 美元 | 升級 | 中性 → 超重 |
| 08/03/2023 | 119.92% | 拉登堡塔爾曼 | 7.5 美元 → 8.5 美元 | 維護 | 買 |
| 04/17/2023 | 81.11% | Wedbush | 6 美元 → 7 美元 | 維護 | 跑贏大盤 |
| 03/03/2023 | 55.24% | Wedbush | 3 美元 → 6 美元 | 升級 | 中性 → 跑贏大盤 |
| 12/30/2022 | 81.11% | 花旗集團 | 6 美元 → 7 美元 | 維護 | 買 |
| 11/17/2022 | 106.99% | 派珀·桑德勒 | 3 美元 → 8 美元 | 升級 | 中性 → 超重 |
| 05/19/2022 | -22.38% | 派珀·桑德勒 | 4 美元 → 3 美元 | 維護 | 中立 |
| 2022 年 6 月 5 日 | — | 坎託·菲茨傑拉德 | 降級 | 超重 → 中性 | |
| 03/02/2022 | 29.37% | 傑富瑞集團 | 1 美元 → 5 美元 | 升級 | 持有 → 買入 |
| 12/01/2021 | 236.35% | 花旗集團 | 7 美元 → 13 美元 | 維護 | 買 |
| 12/01/2021 | 55.24% | 拉登堡塔爾曼 | → 6 美元 | 升級 | 中性 → 買入 |
| 2021 年 10 月 14 日 | — | 拉登堡塔爾曼 | 降級 | 買入 → 中性 | |
| 07/21/2021 | -48.25% | 傑富瑞集團 | 11 美元 → 2 美元 | 降級 | 買入 → 持有 |
| 2021 年 7 月 20 日 | -22.38% | Wedbush | → 3 美元 | 降級 | 跑贏大盤 → 中性 |
| 2021 年 7 月 20 日 | 3.49% | 派珀·桑德勒 | 14 美元 → 4 美元 | 降級 | 超重 → 中性 |
| 03/23/2021 | 262.23% | Wedbush | → 14 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 01/06/2021 | 262.23% | 坎託·菲茨傑拉德 | → 14 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 2020 年 11 月 12 日 | 262.23% | SVB Leerink | 11 美元 → 14 美元 | 維護 | 跑贏大盤 |
| 02/18/2020 | 184.61% | 傑富瑞集團 | → 11 美元 | 假設 | → 購買 |
| 02/12/2020 | 236.35% | 花旗集團 | → 13 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2020 年 10 月 2 日 | — | Cowen & Co. | 啓動覆蓋範圍開啓 | → 跑贏大盤 | |
| 2019 年 9 月 24 日 | 132.86% | SVB Leerink | 8 美元 → 9 美元 | 維護 | 跑贏大盤 |
| 2019 年 8 月 4 日 | — | 派珀·桑德勒 | 啓動覆蓋範圍開啓 | → 超重 |
What is the target price for Ardelyx (ARDX)?
Ardelyx (ARDX) 的目標價格是多少？
The latest price target for Ardelyx (NASDAQ: ARDX) was reported by HC Wainwright & Co. on November 1, 2023. The analyst firm set a price target for $11.00 expecting ARDX to rise to within 12 months (a possible 184.61% upside). 10 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月1日公佈了Ardelyx（納斯達克股票代碼：ARDX）的最新目標股價。該分析公司將目標股價定爲11.00美元，預計ARDX將在12個月內升至12個月內（可能上漲184.61％）。去年有10家分析公司公佈了評級。
What is the most recent analyst rating for Ardelyx (ARDX)?
分析師對Ardelyx (ARDX) 的最新評級是多少？
The latest analyst rating for Ardelyx (NASDAQ: ARDX) was provided by HC Wainwright & Co., and Ardelyx maintained their buy rating.
HC Wainwright & Co. 對Ardelyx（納斯達克股票代碼：ARDX）的最新分析師評級由HC Wainwright & Co. 提供，Ardelyx維持買入評級。
When is the next analyst rating going to be posted or updated for Ardelyx (ARDX)?
Ardelyx (ARDX) 的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ardelyx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ardelyx was filed on November 1, 2023 so you should expect the next rating to be made available sometime around November 1, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Ardelyx的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Ardelyx的最新評級是在2023年11月1日公佈的，因此您應該預計下一個評級將在2024年11月1日左右公佈。
Is the Analyst Rating Ardelyx (ARDX) correct?
分析師對 Ardelyx (ARDX) 的評級是否正確？
While ratings are subjective and will change, the latest Ardelyx (ARDX) rating was a maintained with a price target of $9.00 to $11.00. The current price Ardelyx (ARDX) is trading at is $3.87, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Ardelyx（ARDX）評級維持不變，目標股價爲9.00美元至11.00美元。Ardelyx（ARDX）目前的交易價格爲3.87美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。